Annotated Medicine and Device Lists


Didanosine (ddI)

This medicine is present in:

List Section Observation
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.05. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru 6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors No observations

This medicine is present in:

List Section Observation
Peru 6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors No observations

This medicine is present in:

List Section Observation
Peru 6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors No observations

This medicine is present in:

List Section Observation
Paraguay. Lista de Medicamentos Esenciales. 2009 05. ANTIVIRALES DE USO SISTÉMICO No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.05. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
Chile. Formulario Nacional de Medicamentos. 2005 06.05. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
Paraguay. Lista de Medicamentos Esenciales. 2009 05. ANTIVIRALES DE USO SISTÉMICO No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.05. ANTIVIRALES No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals No observations

Information Resources: Didanosine (ddI)

Loading ...
Loading ...
Loading ...
No information available